Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using predrugs to optimize drug candidates.

Rafik Karaman1

  • 1Al-Quds University, Department of Bioorganic and Pharmaceutical Chemistry, Faculty of Pharmacy , P.O. Box 20002, Jerusalem , Palestine +972 2 2790413 ; +972 2 2790413 ; dr_karaman@yahoo.com.

Expert Opinion on Drug Discovery
|August 29, 2014
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gold Nanoparticles in Biomedical Applications: Synthesis, Functionalization, and Recent Advances.

Molecules (Basel, Switzerland)·2026
Same author

Virosomes: Beyond Vaccines.

Life (Basel, Switzerland)·2025
Same author

Bioorganic Chemistry, Toxinology, and Pharmaceutical Uses of <i>Datura</i> Metabolites and Derivatives.

Toxins·2025
Same author

Exploring the Effects of Oxidative Stress on Female Reproductive Function: The Role of Antioxidant Supplementation.

Current drug metabolism·2025
Same author

Promising Natural Remedies for Alzheimer's Disease Therapy.

Molecules (Basel, Switzerland)·2025
Same author

The Redox Process in Red Blood Cells: Balancing Oxidants and Antioxidants.

Antioxidants (Basel, Switzerland)·2025
Same journal

Why Next-generation mechanistic models Will transform drug discovery: integrating efficacy and safety.

Expert opinion on drug discovery·2026
Same journal

Toward a nuanced framework for the Medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology.

Expert opinion on drug discovery·2026
Same journal

From mitochondrial signal to discovery decision: a reserve-demand framework for translational risk assessment.

Expert opinion on drug discovery·2026
Same journal

Advances in 3D cell culture models for alzheimer's disease drug discovery.

Expert opinion on drug discovery·2026
Same journal

Are patient-derived models of amyotrophic lateral sclerosis a game changer for novel drug discovery?

Expert opinion on drug discovery·2026
Same journal

Unfolding prion misfolding and the challenge of identifying effective therapeutics: is there hope on the horizon?

Expert opinion on drug discovery·2026
See all related articles

The predrug approach offers a cost-effective strategy for developing new drugs with improved efficacy, selectivity, and reduced toxicity. This method enhances drug delivery by overcoming pharmacokinetic barriers like poor bioavailability and short action duration.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Drug Discovery

Background:

  • Traditional drug discovery is time-consuming and expensive.
  • Predrug strategies offer a cheaper, faster alternative for developing new chemical entities.
  • Predrugs can exhibit superior efficacy, selectivity, and reduced toxicity compared to parent drugs.

Purpose of the Study:

  • To define predrugs and explain their strategic use in overcoming pharmaceutical barriers.
  • To highlight how predrugs improve drug properties like bioavailability, absorption, and duration of action.
  • To discuss the role of predrugs in enhancing site selectivity and reducing toxicity.

Main Methods:

  • Review of general terms and concepts related to predrugs.
  • Analysis of approaches utilizing predrug strategy to address pharmacokinetic challenges.
Keywords:
drugspharmacokinetic and pharmaceutical barriersphysicochemical propertiespredrug approachespredrugsprodrugsquantum mechanicstargeted predrugs

Related Experiment Videos

  • Examination of how polarity alteration, site selectivity, and duration modification are achieved through predrugs.

    • Main Results:

    • Predrug utilization has resulted in successful drug development with enhanced bioavailability.
    • The strategy effectively improves drug targeting efficiency and patient compliance.
    • Predrugs can overcome barriers such as poor solubility, low absorption, and rapid metabolism.

    Conclusions:

    • The predrug approach has a proven track record of success in drug development.
    • Future advancements require deeper understanding of organic reaction mechanisms and enzyme structures in predrug activation.
    • Predrug technology promises safe and effective delivery of diverse therapeutics, including small molecules and biotherapeutics.